Xanthomonas bacteriolytic bacteriophage

JPWO2023191073A5Pending Publication Date: 2026-04-02
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Filing Date
2023-03-31
Publication Date
2026-04-02

AI Technical Summary

Technical Problem

Current methods for controlling plant diseases caused by Xanthomonas bacteria, such as copper agents and antibiotics, face issues like limited efficacy, damage to crops, and disruption of bacterial flora balance, necessitating the development of a more targeted and safer approach.

Method used

Isolation and use of novel bacteriophages with specific lytic activity against Xanthomonas bacteria, which are highly specific to their host and environmentally safe, utilizing their genomic DNA sequences to recognize and infect target bacteria, thereby controlling plant diseases.

Benefits of technology

The novel bacteriophages effectively lyse target Xanthomonas bacteria, providing a targeted and safe solution for plant disease control that minimizes impact on non-target bacteria and the environment.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

To isolate a novel bacteriophage exhibiting bacteriolytic activity specific to bacteria of the genus Xanthomonas in order to control plant diseases caused by Xanthomonas bacteria, and to develop and provide a plant disease control composition having the bacteriophage as an active ingredient.　Provided are a bacteriolytic agent composed of a bacteriophage having a novel genomic DNA sequence and exhibiting bacteriolytic activity specific to bacteria of the genus Xanthomonas, and a plant disease control composition having the bacteriolytic agent as an active ingredient.
Need to check novelty before this filing date? Find Prior Art